Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cba9c682c8c191566bfc5e9fa4ed9e93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d82107255fcb7ee50d3a2aaa8b5664dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18571 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-135 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48215 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005 |
filingDate |
2012-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b8d77c07ca560b690c260e0f2eab8e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab563ffd3e21cd45041f3fa8da2e7fd6 |
publicationDate |
2014-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014370042-A1 |
titleOfInvention |
Stabilized Antiviral Fusion Helices |
abstract |
Internally cross-linked peptides useful for interfering with Respiratory Syncytial Virus (RSV) infection is based on RSV-F protein. These peptides are capable of reducing infection in cellular and animal models. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11325955-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016287754-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018527306-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017147283-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017040323-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-256395-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019178313-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017004591-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017004591-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11078246-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10464975-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018170299-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108026146-A |
priorityDate |
2011-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |